Maternal asthma and maternal smoking are associated with increased risk of bronchiolitis during infancy

Kecia N Carroll1, Tebeb Gebretsadik, Marie R Griffin

  • 1Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. tina.hartert@vanderbilt.edu

Pediatrics
|June 5, 2007
PubMed

Insights

Maternal asthma and smoking during pregnancy increase infant bronchiolitis risk. Infants born to mothers with both conditions face the highest risk of severe illness and hospitalization.

Area of Science:

  • Pediatric respiratory health
  • Epidemiology of infant infections
  • Environmental and genetic factors in infant disease

Background:

  • Bronchiolitis is a leading cause of infant hospitalization.
  • Identifying risk factors for severe bronchiolitis is crucial for prevention.
  • Maternal health conditions and behaviors during pregnancy may impact infant respiratory outcomes.

Purpose of the Study:

  • To investigate the association between maternal asthma and maternal smoking during pregnancy and the incidence and severity of clinically significant bronchiolitis in term infants.
  • To exclude confounding factors such as small lung size or underlying cardiac/pulmonary disease.

Main Methods:

  • Population-based retrospective cohort study of term, non-low birth weight infants in Tennessee (1995-2003).
  • Follow-up through the first year of life to assess bronchiolitis incidence and severity.
  • Severity determined by healthcare visits and prolonged hospitalization (>3 days).

Main Results:

  • A total of 101,245 infants were included; 20% experienced at least one healthcare visit for bronchiolitis.
  • Maternal smoking and/or asthma independently increased the risk of bronchiolitis.
  • Infants with maternal asthma (alone or with smoking) had the highest risk for emergency department visits and hospitalizations.

Conclusions:

  • Maternal asthma and smoking are independent risk factors for infant bronchiolitis in otherwise healthy term infants.
  • Infants of mothers with both asthma and smoking have a significantly elevated risk of bronchiolitis.
  • Reducing exposure to these maternal risk factors could decrease infant morbidity from bronchiolitis.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: